EN523
CAS No. 2094893-05-5
EN523 ( —— )
Catalog No. M28951 CAS No. 2094893-05-5
EN523 targets non-catalytic allosteric cysteine C23 in K48 ubiquitin-specific deuquitinase OTUB1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 147 | Get Quote |
|
10MG | 260 | Get Quote |
|
25MG | 520 | Get Quote |
|
50MG | 750 | Get Quote |
|
100MG | 1035 | Get Quote |
|
500MG | 2061 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEN523
-
NoteResearch use only, not for human use.
-
Brief DescriptionEN523 targets non-catalytic allosteric cysteine C23 in K48 ubiquitin-specific deuquitinase OTUB1.
-
DescriptionEN523 targets non-catalytic allosteric cysteine C23 in K48 ubiquitin-specific deuquitinase OTUB1.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorNav1.7 channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2094893-05-5
-
Formula Weight234.3
-
Molecular FormulaC12H14N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=CC=C(O1)N1CCN(CC1=O)C(=O)C=C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kornecook TJ, et al. Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel NaV1.7. J Pharmacol Exp Ther. 2017 Jul;362(1):146-160.
molnova catalog
related products
-
Glucotropaeolin pota...
Glucotropaeolin potassium is found in cruciferous vegetables and moderately decrease spontaneous DNA damage in animals.
-
PXS-5153A
PXS-5153A is an effective, selective, and fast-acting inhibitor of lysyl oxidase like 2/3 enzymes with enzymatic activity almost entirely blocked within 15 minutes. PXS-5153A could reduce crosslinks and ameliorates fibrosis.
-
Atracurium besylate
Atracurium besylate is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.